Premium
Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype
Author(s) -
Bowron Ann,
Honeychurch Julie,
Williams Maggie,
TsaiGoodman Beverley,
Clayton Nicol,
Jones Lucy,
Shortland Graham J.,
Qureshi Shakeel A.,
Heales Simon J. R.,
Steward Colin G.
Publication year - 2015
Publication title -
journal of inherited metabolic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1007/s10545-014-9747-y
Subject(s) - cardiolipin , medicine , asymptomatic , cardiomyopathy , pathological , cardiology , endocrinology , heart failure , genetics , biology , phospholipid , membrane
Barth syndrome (BTHS) is an X‐linked disorder characterised by cardiac and skeletal myopathy, growth delay, neutropenia and 3‐methylglutaconic aciduria (3‐MGCA). Patients have TAZ gene mutations which affect metabolism of cardiolipin, resulting in low tetralinoleoyl cardiolipin (CL 4 ), an increase in its precursor, monolysocardiolipin (MLCL), and an increased MLCL/CL 4 ratio. During development of a diagnostic service for BTHS, leukocyte CL 4 was measured in 156 controls and 34 patients with genetically confirmed BTHS. A sub‐group of seven subjects from three unrelated families was identified with leukocyte CL 4 concentrations within the control range. This had led to initial false negative disease detection in two of these patients. MLCL/CL 4 in this subgroup was lower than in other BTHS patients but higher than controls, with no overlap between the groups. TAZ gene mutations in these families are all predicted to be pathological. This report describes the clinical histories of these seven individuals with an atypical phenotype: some features were typical of BTHS (five have had cardiomyopathy, one family has a history of male infant deaths, three have growth delay and five have 3‐MGCA) but none has persistent neutropenia, five have excellent exercise tolerance and two adults are asymptomatic. This report also emphasises the importance of measurement of MLCL/CL 4 ratio rather than CL 4 alone in the biochemical diagnosis of the BTHS.